SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040964
Filing Date
2023-08-10
Accepted
2023-08-10 07:44:59
Documents
68
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cgem-20230630.htm   iXBRL 10-Q 2470418
2 EX-10.1 cgem-ex10_1.htm EX-10.1 140410
3 EX-10.2 cgem-ex10_2.htm EX-10.2 24674
4 EX-31.1 cgem-ex31_1.htm EX-31.1 18011
5 EX-31.2 cgem-ex31_2.htm EX-31.2 17757
6 EX-32.1 cgem-ex32_1.htm EX-32.1 17719
  Complete submission text file 0000950170-23-040964.txt   8858099

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cgem-20230630.xsd EX-101.SCH 68727
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cgem-20230630_def.xml EX-101.DEF 172522
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cgem-20230630_cal.xml EX-101.CAL 43512
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cgem-20230630_lab.xml EX-101.LAB 461915
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cgem-20230630_pre.xml EX-101.PRE 338791
62 EXTRACTED XBRL INSTANCE DOCUMENT cgem-20230630_htm.xml XML 1646521
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39856 | Film No.: 231157220
SIC: 2836 Biological Products, (No Diagnostic Substances)